K. Ligier, A. Belot, and G. Launoy, Descriptive epidemiology of upper aerodigestive tract cancers in France: Incidence over 1980-2005 and projection to 2010, Oral Oncol, vol.47, issue.4, pp.302-307, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00698021

, Guide -Affection longue durée -Cancer des voies aérodigestives supérieures. Haute Autorité Santé Guid ALD 30, 2009.

A. K. Chaturvedi, W. F. Anderson, and J. Lortet-tieulent, Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers, J Clin Oncol, vol.31, issue.36, pp.4550-4559, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01261786

E. P. Simard, L. A. Torre, and A. Jemal, International trends in head and neck cancer incidence rates: Differences by country, sex and anatomic site, Oral Oncol, vol.50, issue.5, pp.387-403, 2014.

G. D'souza, A. R. Kreimer, and R. Viscidi, Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer, N Engl J Med, vol.356, pp.1944-1956, 2007.

M. L. Gillison, Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers, J Natl Cancer Inst, vol.92, issue.9, pp.709-720, 2000.

A. K. Chaturvedi, E. A. Engels, and R. M. Pfeiffer, Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States, J Clin Oncol, vol.29, issue.32, pp.4294-4301, 2011.

A. R. Kreimer, G. M. Clifford, P. Boyle, and S. Franceschi, Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review, Cancer Epidemiol Biomarkers Prev, vol.14, issue.2, pp.467-475, 2005.

B. G. Hansson, K. Rosenquist, and A. Antonsson, Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden, Acta Otolaryngol, vol.125, issue.12, pp.1337-1344, 2005.

S. Habbous, K. P. Chu, and H. Lau, Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation, CMAJ, vol.189, issue.32, pp.1030-1040, 2017.

V. Bouvard, R. Baan, and K. Straif, A review of human carcinogens--Part B: biological agents, Lancet Oncol, vol.10, issue.4, pp.321-322, 2009.

E. S. Agoston, S. J. Robinson, and K. K. Mehra, Polymerase Chain Reaction Detection of HPV in Squamous Carcinoma of the Oropharynx, Am J Clin Pathol, vol.134, issue.1, pp.36-41, 2010.

J. A. Bishop, X. Ma, and H. Wang, Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method, Am J Surg Pathol, vol.36, issue.12, pp.1874-1882, 2012.

P. Boscolo-rizzo, M. Pawlita, and D. Holzinger, From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas, Cancer Treat Rev, vol.42, pp.24-29, 2016.

A. K. El-naggar, W. H. Westra, . Surrogate-marker-for, . Hpv-related, and . Oropharyngeal-carcinoma, A GUIDE FOR INTERPRETATIVE RELEVANCE AND CONSISTENCY. Head Neck, vol.36, issue.10, p.1391, 2012.

N. F. Schlecht, M. Brandwein-gensler, and G. J. Nuovo, A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer, Mod Pathol, vol.24, issue.10, pp.1295-1305, 2011.

R. C. Jordan, M. W. Lingen, and B. Perez-ordonez, Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials, Am J Surg Pathol, vol.36, issue.7, pp.945-954, 2012.

J. S. Lewis, p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma, Head Neck Pathol, vol.6, issue.1, pp.75-82, 2012.

L. Licitra, F. Perrone, and P. Bossi, High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma, J Clin Oncol, vol.24, issue.36, pp.5630-5636, 2006.

F. Perrone, A. Gloghini, and B. Cortelazzi, Isolating p16-positive/`HPV-negative oropharyngeal cancer : an effort worth making, Am J Surg Pathol, vol.35, issue.5, pp.774-777, 2011.

H. Razzaghi, M. Saraiya, T. D. Thompson, S. J. Henley, L. Viens et al., Five-year relative survival for human papillomavirus-associated cancer sites. Cancer, vol.124, pp.203-211, 2018.

M. L. Gillison, D. Souza, G. Westra, and W. , Distinct Risk Factor Profiles for Human Papillomavirus Type 16?Positive and Human Papillomavirus Type 16?Negative Head and Neck Cancers, JNCI J Natl Cancer Inst, vol.100, issue.6, pp.407-420, 2008.

M. L. Gillison, A. K. Chaturvedi, W. F. Anderson, and C. Fakhry, Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma, J Clin Oncol, vol.33, issue.29, pp.3235-3242, 2015.

M. H. Stenmark, D. Shumway, and C. Guo, Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States, Laryngoscope, vol.127, issue.10, pp.2270-2278, 2017.

D. Urban, J. Corry, and D. Rischin, What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?, Cancer, vol.120, issue.10, pp.1462-1470, 2014.

M. R. Posner, J. H. Lorch, and O. Goloubeva, Survival and human papillomavirus in oropharynx cancer in TAX 324: A subset analysis from an international phase III trial

, Ann Oncol, vol.22, issue.5, pp.1071-1077, 2011.

K. S. Louie, H. Mehanna, and P. Sasieni, Trends in head and neck cancers in England from 1995 to 2011 and projections up to 2025, Oral Oncol, vol.51, issue.4, pp.341-348, 2015.

M. Evans, R. Newcombe, and A. Fiander, Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population, BMC Cancer, vol.13, issue.1, p.220, 2013.

C. Ndiaye, M. Mena, and L. Alemany, HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: A systematic review and meta-analysis, Lancet Oncol, vol.15, issue.12, pp.1319-1331, 2014.

D. Fonmarty, S. Cherrière, and H. Fleury, Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma, Eur Ann Otorhinolaryngol Head Neck Dis, vol.132, issue.3, pp.135-139, 2015.

R. Granata, R. Miceli, and E. Orlandi, Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study, Ann Oncol, vol.23, issue.7, pp.1832-1837, 2012.

M. G. Donà, G. Spriano, and B. Pichi, Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from, Future Microbiol, vol.10, issue.8, pp.1283-1291, 2010.

P. Morbini and M. Benazzo, Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data, Acta Otorhinolaryngol Ital, vol.36, issue.4, pp.249-258, 2016.

M. Mena, M. Taberna, and S. Tous, Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients, Oral Oncol, vol.78, pp.137-144, 2018.

L. St-guily, J. Rousseau, A. Baujat, and B. , Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study, Oral Oncol, vol.67, pp.29-36, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02451668

K. K. Ang, J. Harris, and R. Wheeler, Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer, N Engl J Med, vol.363, issue.1, pp.24-35, 2010.

S. S. Hecht, Tobacco carcinogens, their biomarkers and tobacco-induced cancer, Nat Rev Cancer, vol.3, issue.10, pp.733-744, 2003.

M. Taberna, M. Mena, M. A. Pavón, L. Alemany, M. L. Gillison et al., Human papillomavirus-related oropharyngeal cancer, Ann Oncol, vol.28, issue.10, pp.2386-2398, 2017.

D. Goldenberg, S. Begum, and W. H. Westra, Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon, Head Neck, vol.30, issue.7, pp.898-903, 2008.

D. Culié, Stratégie thérapeutique des cancers de l ' oropharynx : Étude multicentrique rétrospective Avant-propos et Remerciements, 2018.

D. Rischin, R. J. Young, and R. Fisher, Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial, J Clin Oncol, vol.28, issue.27, pp.4142-4148, 2010.

C. Fakhry, W. H. Westra, and S. Li, Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial, J Natl Cancer Inst, vol.100, issue.4, pp.261-269, 2008.

S. H. Huang and B. O'sullivan, National Cancer Institute. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) -Head and Neck Cancers. Version 2, Curr Treat Options Oncol, vol.18, issue.7, 2017.

T. Brown, M. Banks, B. Hughes, C. Lin, L. M. Kenny et al., Impact of early prophylactic feeding on long term tube dependency outcomes in patients with head and neck cancer, Oral Oncol, vol.72, pp.17-25, 2017.

P. Boscolo-rizzo, M. Stellin, R. Fuson, C. Marchiori, A. Gava et al., Long-term quality of life after treatment for locally advanced oropharyngeal carcinoma: Surgery and postoperative radiotherapy versus concurrent chemoradiation, Oral Oncol, vol.45, issue.11, pp.953-957, 2009.

H. Mirghani, F. Amen, and P. Blanchard, Treatment de-escalation in HPV-positive oropharyngeal carcinoma: Ongoing trials, critical issues and perspectives, Int J Cancer, vol.136, issue.7, pp.1494-1503, 2015.

M. Theodoraki, J. A. Veit, T. K. Hoffmann, and J. Greve, Synchronous bilateral tonsil carcinoma: case presentation and review of the literature. Infect Agent Cancer, 2017.

D. Société-française, Bilan préthérapeutique des carcinomes épidermoïdes des VADS. Recomm pour la Prat Clin, vol.2012, pp.8-13

K. Hujala, J. Sipilä, and R. Grenman, Panendoscopy and synchronous second primary tumors in head and neck cancer patients, Eur Arch Oto-Rhino-Laryngology, vol.262, issue.1, pp.17-20, 2005.


S. Slaughter-dp, . Hw, and . Smejkal-w, Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin, Cancer, vol.6, issue.5, pp.963-968, 1953.

G. D. Dakubo, J. P. Jakupciak, M. A. Birch-machin, and R. L. Parr, Clinical implications and utility of field cancerization, Cancer Cell Int, vol.7, pp.1-12, 2007.

V. Kadashetti, K. Shivakumar, and R. Baad, Field cancerization in stomatognathic system, CHRISMED J Heal Res, vol.3, issue.4, p.247, 2016.

C. B. Nelem-colturato, P. M. Cury, and T. M. Pereira, Sextuple Tumors in Head and Neck Area: Evidence of Field Cancerization, Case Rep Pathol, vol.2018, pp.1-4, 2018.

, Oncol Rev, vol.8, issue.1, 2014.

B. N. Gomperts, T. C. Walser, A. Spira, and S. M. Dubinett, Enriching the molecular definition of the airway "Field of cancerization, Cancer Prev Res, vol.6, issue.1, pp.4-7, 2013.

B. Braakhuis, M. P. Tabor, J. A. Kummer, R. H. Brakenhoff, and R. C. , Perspectives in Cancer Research A Genetic Explanation of Slaughter ' s Concept of Field Cancerization : Evidence and, Oncology, pp.1727-1730, 2003.

, Alcool et risque de cancers : état des lieux des données scientifiques et recommandations de santé publique, 2007.

, Haute Autorité de Santé -Institut National du cancer. PAPILLOMAVIRUS ET CANCER, 2018.

K. S. Jain, A. G. Sikora, S. S. Baxi, and L. Morris, Synchronous cancers in patients with head and neck cancer: Risks in the era of human papillomavirus-associated oropharyngeal cancer, Cancer, vol.119, issue.10, pp.1832-1837, 2013.

L. St-guily, J. Rousseau, A. Baujat, and B. , Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study, Oral Oncol, vol.67, pp.29-36, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02451668

H. Mirghani and J. L. Saint-guily, Papillomavirus humain et cancer de l'oropharynx

R. Garrel, J. Viotti, and R. Schiappa, European Journal of Surgical Oncology Impact of HPV-associated p16-expression and other clinical factors on therapeutic decisionmaking in patients with oropharyngeal cancer : A GETTEC multicentric study d e, vol.44, pp.1908-1913, 2018.

S. Warren and O. Gates, Multiple malignant tumors: a survey of literature and statistical study, Am J Cancer, vol.51, pp.1358-1414, 1932.

G. Larsen, C. Gyldenløve, M. Jensen, and D. H. , Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review

, Br J Cancer, vol.110, issue.6, pp.1587-1594, 2014.

S. Marur, D. Souza, G. Westra, W. H. Forastiere, and A. A. , HPV-associated head and neck cancer: a virus-related cancer epidemic, Lancet Oncol, vol.11, issue.8, pp.70017-70023, 2010.

L. Morris, A. G. Sikora, R. B. Hayes, S. G. Patel, and I. Ganly, Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer, Cancer Causes Control, vol.22, issue.5, pp.671-679, 2011.

X. León, M. Quer, S. Diez, C. Orús, A. López-pousa et al., Second neoplasm in patients with head and neck cancer, Head Neck, vol.21, issue.3, pp.204-210, 1999.

E. M. Sturgis and R. H. Miller, Second Primary Malignancies in the Head and Neck Cancer Patient, Ann Otol Rhinol Laryngol, vol.104, issue.12, pp.946-954, 1995.

Y. Saito, Y. Ebihara, and T. Ushiku, Negative human papillomavirus status and excessive alcohol consumption are significant risk factors for second primary malignancies in japanese patients with oropharyngeal carcinoma, Jpn J Clin Oncol, vol.44, issue.6, pp.564-569, 2014.

C. Badoual, J. Pavie, and M. Ménard, Consultation multidisciplinaire pour les patients atteints d'une pathologie tumorale (carcinome infiltrant ou lésion précancéreuse) liée à HPV : la consultation multidisciplinaire papillomavirus Multidisciplinary consultation for patients with HPV-related, Cancer/Radiothérapie, vol.22, pp.487-491, 2018.

C. N. Saber, C. Grønhøj, and D. H. Jensen, Synchronous, bilateral tonsillar carcinomas: Patient characteristics and human papillomavirus genotypes, Oral Oncol, vol.74, pp.105-110, 2017.

S. Nakahara, T. Yasui, and Y. Takenaka, Synchronous bilateral tonsillar carcinomas associated with human papillomavirus, 2014.

F. Shimizu, K. Okami, and K. Ebisumoto, Synchronous HPV-Related Cancer of Bilateral Tonsils Detected Using Transoral Endoscopic Examination with Narrow-Band Imaging, 2017.

M. M. Roeser, E. E. Alon, K. D. Olsen, E. J. Moore, M. Manduch et al., Synchronous bilateral tonsil squamous cell carcinoma, Laryngoscope, vol.120, p.2010, 2010.

A. W. Joseph, T. Ogawa, and J. A. Bishop, Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas

, Oral Oncol, vol.49, issue.3, pp.244-248, 2013.

S. L. Mcgovern, M. D. Williams, and R. S. Weber, Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization, Head Neck, vol.32, issue.8, pp.1118-1124, 2010.

M. Hampl, N. Wentzensen, and S. Vinokurova, Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile, J Cancer Res Clin Oncol, vol.133, issue.4, pp.235-245, 2007.

A. M. Hong, A. Martin, and M. Chatfield, Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma, Int J Cancer, vol.132, issue.12, pp.2748-2754, 2013.

A. R. Kompelli, P. Morgan, H. Li, W. Harris, T. A. Day et al., Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use. Otolaryngol -Head Neck Surg (United States), vol.160, pp.855-861, 2019.

P. R. Prabhu, D. Jayalekshmi, and M. R. Pillai, Lung Cancer and Human Papilloma Viruses (HPVs): Examining the Molecular Evidence, J Oncol, vol.2012, pp.1-10, 2012.

C. C. Xu, V. L. Biron, L. Puttagunta, and H. Seikaly, HPV Status and second primary tumours in Oropharyngeal Squamous Cell Carcinoma, J Otolaryngol -Head Neck Surg, vol.42, p.1, 2013.

O. Malard and R. Abgral, Recommandations de bonne pratique clinique pour l'utilisation de la, TEP en cancérologie. THESAURUS, pp.21-59, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02089804

N. Kondo, M. Tsukuda, and G. Nishimura, Diagnostic sensitivity of 18fluorodeoxyglucose positron emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients, Eur Arch Oto-Rhino-Laryngology, vol.269, issue.5, pp.1503-1507, 2012.

J. Gilbert, M. L. Gillison, and R. I. Haddad, NCCN Guidelines Version 2.2016 Panel Members Head and Neck Cancers, 2016.

R. De-bree, E. E. Deurloo, G. B. Snow, and C. R. Leemans, Screening for Distant Metastases in Patients With Head and Neck Cancer, Laryngoscope, vol.110, issue.3, pp.397-401, 2000.

K. S. Loh, D. H. Brown, J. T. Baker, R. W. Gilbert, P. J. Gullane et al., A rational approach to pulmonary screening in newly diagnosed head and neck cancer, Head Neck, vol.27, issue.11, pp.990-994, 2005.

K. Hori, H. Okada, and Y. Kawahara, Lugol-Voiding Lesions Are an Important Risk Factor for a Second Primary Squamous Cell Carcinoma in Patients With Esosphageal Cancer or Head and Neck Cancer, Am J Gastroenterol, vol.106, issue.5, pp.858-866, 2011.

M. A. Pasha, C. Marcus, C. Fakhry, H. Kang, A. P. Kiess et al., FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity, AJR Am J Roentgenol, vol.205, issue.2, pp.150-61, 2015.

H. Mirghani and P. Blanchard, Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?, Clin Transl Radiat Oncol, vol.8, pp.4-11, 2017.

K. Rodriguez-bruno, M. J. Ali, and S. J. Wang, Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oropharyngeal squamous cell carcinoma, Head Neck, vol.33, issue.7, pp.949-953, 2011.

D. Pulte and H. Brenner, Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis, Oncologist, vol.15, issue.9, pp.994-1001, 2010.

S. M. Bluethmann, A. B. Mariotto, and J. H. Rowland, Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States, Cancer Epidemiol Biomarkers Prev, vol.25, issue.7, pp.1029-1036, 2016.

L. J. Viens, S. J. Henley, and M. Watson, Human Papillomavirus-Associated Cancers -United States, MMWR Morb Mortal Wkly Rep, vol.65, issue.26, pp.661-666, 2008.

P. Boffetta and M. Hashibe, Alcohol and cancer, Lancet Oncol, vol.7, issue.2, pp.149-156, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01260905

H. Cataloiu, A. Danciu, C. E. Popescu, and C. R. , Multiple cancers of the head and neck

, Maedica (Buchar), vol.8, issue.1, pp.80-85, 2013.

S. Henderson, A. Chakravarthy, X. Su, C. Boshoff, and T. R. Fenton, APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development, Cell Rep, vol.7, issue.6, pp.1833-1841, 2014.

P. Baumeister, M. Märte, M. Reiter, C. Welz, S. Schwenk-zieger et al., EGFR and P-GP expression in oropharyngeal mucosa in relation to smoking, Anticancer Res, vol.32, issue.5, pp.1639-1648, 2012.

M. A. Sartor, D. C. Dolinoy, and T. R. Jones, Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis, Epigenetics, vol.6, issue.6, pp.777-787, 2011.

P. S. Hammerman, D. N. Hayes, and J. R. Grandis, Therapeutic Insights from Genomic Studies of Head and Neck Squamous Cell Carcinomas, Cancer Discov, vol.5, issue.3, pp.239-244, 2015.

Y. Saito, Y. Ebihara, and T. Ushiku, Negative Human Papillomavirus Status and Excessive Alcohol Consumption are Significant Risk Factors for Second Primary Malignancies in Japanese Patients with Oropharyngeal Carcinoma ?, Jpn J Clin Oncol, vol.44, issue.6, pp.564-569, 2014.

A. Boakye, E. Buchanan, P. Hinyard, L. Osazuwa-peters, N. Schootman et al., Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma, JAMA Otolaryngol Neck Surg, vol.144, issue.8, p.727, 2018.

C. Haremza, M. Baert, C. Pascual, A. Biet-hornstein, and C. Page, Head and neck squamous cell carcinoma and metachronous second primaries. Eur Ann Otorhinolaryngol Head Neck Dis, 2019.

M. S. Tiwana, J. Hay, J. Wu, F. Wong, W. Cheung et al., Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years

, Laryngoscope, vol.124, issue.10, pp.2287-2291, 2014.

L. Morris, A. G. Sikora, S. G. Patel, R. B. Hayes, and I. Ganly, Second primary cancers after an index head and neck cancer: Subsite-specific trends in the era of human papillomavirus -Associated oropharyngeal cancer, J Clin Oncol, vol.29, issue.6, pp.739-746, 2011.

T. Tabuchi, Y. Ito, A. Ioka, I. Miyashiro, and H. Tsukuma, Incidence of metachronous second primary cancers in Osaka, Japan: Update of analyses using population-based cancer registry data, Cancer Sci, vol.103, issue.6, pp.1111-1120, 2012.

D. P. Slaughter, H. W. Southwick, and W. Smejkal, Field cancerization" in oral stratified squamous epithelium. Clinical implications of multicentric origin, Cancer, vol.6, issue.5, pp.963-968, 1953.

B. Braakhuis, M. P. Tabor, J. A. Kummer, C. R. Leemans, and R. H. Brakenhoff, A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications, Cancer Res, vol.63, issue.8, pp.1727-1730, 2003.

J. Califano, P. Van-der-riet, and W. Westra, Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization1, 1996.

M. Kato, R. Ishihara, and K. Hamada, Endoscopic surveillance of head and neck cancer in patients with esophageal squamous cell carcinoma, Endosc Int Open, vol.04, issue.07, pp.752-755, 2016.

N. Dulguerov and P. Dulguerov, The indication of panendoscopy in the search for synchronous and metachronous head and neck cancer

, Rev Med Suisse, vol.9, issue.400, pp.1770-1772, 2013.

. Accessed, , 2019.

M. E. Leon, A. Lugo, and P. Boffetta, Smokeless tobacco use in Sweden and other 17 European countries, Eur J Public Health, vol.26, issue.5, pp.817-821, 2016.

M. C. Kulik and S. A. Glantz, The smoking population in the USA and EU is softening not hardening, Tob Control, vol.25, issue.4, pp.470-475, 2016.

K. B. Pytynia, K. R. Dahlstrom, and E. M. Sturgis, Epidemiology of HPV-associated oropharyngeal cancer, Oral Oncol, vol.50, issue.5, pp.380-386, 2014.

P. M. Weinberger, Z. Yu, and B. G. Haffty, Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis, J Clin Oncol, vol.24, issue.5, pp.736-747, 2006.

E. Leoncini, W. Ricciardi, and G. Cadoni, Adult height and head and neck cancer: A pooled analysis within the INHANCE Consortium, Head Neck, vol.36, issue.10, p.1391, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01261722

S. C. Ritoe, P. Krabbe, and M. Jansen, Screening for second primary lung cancer after treatment of laryngeal cancer, Laryngoscope, vol.112, issue.11, pp.2002-2008, 2002.

J. K. Frost, W. C. Ball, and M. L. Levin, Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study, Am Rev Respir Dis, vol.130, issue.4, pp.549-554, 1984.

K. J. Syrjänen, Condylomatous Changes in Neoplastic Bronchial Epithelium. Respiration, vol.38, issue.5, pp.299-304, 1979.

K. Zhai, J. Ding, and H. Shi, HPV and lung cancer risk: A meta-analysis, J Clin Virol, vol.63, pp.84-90, 2015.

M. M. Tsyganov, A. M. Pevzner, M. K. Ibragimova, I. V. Deryusheva, and N. Litviakov, Human papillomavirus and lung cancer: an overview and a meta-analysis, J Cancer Res Clin Oncol, vol.145, issue.8, pp.1919-1937, 2019.

J. Ichinose, A. Shinozaki-ushiku, D. Takai, M. Fukayama, and J. Nakajima, Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma, Expert Rev Anticancer Ther, vol.16, issue.4, pp.403-410, 2016.

K. K. Vankoevering, E. Marchiano, and H. M. Walline, An Algorithm to Evaluate Suspected Lung Metastases in Patients with HPV-Associated Oropharyngeal Cancer

, Otolaryngol Neck Surg, vol.158, issue.1, pp.118-121, 2018.

A. G. Schache, T. Liloglou, and J. M. Risk, Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination, Clin Cancer Res, vol.17, issue.19, pp.6262-6271, 2011.

C. I. Henschke, D. I. Mccauley, and D. F. Yankelevitz, Early Lung Cancer Action Project: overall design and findings from baseline screening, Lancet, vol.354, issue.9173, pp.99-105, 1999.

P. Barry-béatrix, P. Dominique, C. Pr, and C. Vincent, Participants Promoteur: La Société Française d'Oto-Rhino-Laryngologie et de Chirurgie de La Face et Du Cou COMITE D'ORGANISATION GROUPE DE RELECTURE Organisation : Société Française d'Oto-Rhino-Laryngologie et de Chirurgie de La Face et Du Cou, 2019.

S. S. Coughlin, Epidemiology of Breast Cancer in Women, Advances in Experimental Medicine and Biology, vol.1152, pp.9-29

O. Bugter, D. Van-iwaarden, and E. Dronkers, Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable, Head Neck, vol.41, issue.6, pp.1648-1655, 2019.

B. H. Haughey, G. A. Gates, C. L. Arfken, and J. Harvey, Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol, Ann Otol Rhinol Laryngol, vol.101, issue.2, pp.105-112, 1992.

Y. Su, W. Chen, and H. Chuang, Effect of routine esophageal screening in patients with head and neck cancer, JAMA Otolaryngol Head Neck Surg, vol.139, issue.4, pp.350-354, 2013.

M. Martel, L. Alemany, and M. Taberna, The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma, Oral Oncol, vol.64, pp.37-43, 2017.

R. Suk, P. Mahale, and K. Sonawane, Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers, JAMA Netw Open, vol.1, issue.5, p.181999, 2018.

E. S. Amirian, P. A. Fickey, M. E. Scheurer, and E. Y. Chiao, Anal Cancer Incidence and Survival: Comparing the Greater San-Francisco Bay Area to Other SEER Cancer Registries

S. Savas and E. , PLoS One, vol.8, issue.3, p.58919, 2013.

M. S. Patrucco and M. V. Aramendi, Prognostic impact of second primary tumors in head and neck cancer, Eur Arch Otorhinolaryngol, vol.273, issue.7, pp.1871-1877, 2016.

Y. Jung, J. Lim, K. Jung, J. Ryu, and Y. Won, Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort, vol.10, p.134160, 1993.

A. S. Jones, P. Morar, D. E. Phillips, J. K. Field, D. Husband et al., Second primary tumors in patients with head and neck squamous cell carcinoma, Cancer, vol.75, issue.6, pp.1343-1353, 1995.

E. Rennemo, U. Zätterström, and M. Boysen, In response to Impact of Second Primary Tumors on Survival in Head and Neck Cancer: An Analysis of 2,063 Cases, Laryngoscope, vol.118, issue.7, pp.1447-1447, 2008.

K. Manikantan, R. C. Dwivedi, S. I. Sayed, K. Pathak, and R. Kazi, Current concepts of surveillance and its significance in head and neck cancer, Ann R Coll Surg Engl, vol.93, issue.8, pp.576-582, 2011.

, Annexe 2 : Calendrier de surveillance des cancers des VADS selon la SFORL : Annexe 3 : Score ASA Serment d'Hippocrate Le serment d'Hippocrate

, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Admis(e) dans l'intimité des personnes, je tairai les secrets qui me seront confiés

, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses ; que je sois déshonoré et méprisé si j'y manque